COVID-19 vaccine development: What lessons can we learn from TB?
The SARS-CoV-2 virus has infected more than 49 million people causing more than 1.2 million deaths worldwide since its emergence from Wuhan, China in December 2019. Tuberculosis is also a major infectious respiratory disease of the worldwide prevalence and vaccine development for tuberculosis has been ongoing for decades. we highlight some of the common features, challenges, and complications in tuberculosis vaccine development, which may also be relevant for, and inform COVID-19 vaccine develop

Related Post